Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC)

Sponsor: Charles S. Grob, M.D.
Collaborator: University of California, San Francisco
Recruitment Status: Not yet recruiting
First Posted: Jun 3, 2022

~

Psychedelic Psychiatry (Harjai)

Published: Jun 31, 2022
Advances in Clinical Medical Research and Healthcare Delivery

~

Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial (Marseille et al.)

Published: Jun 2, 2022
PLoS ONE

~

Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder (D’Souza et al.)

Published: Jun 3, 2022
Neuropsychopharmacology